NIH-funded research R21 grant

Flexible 3D‑printed biodegradable implants for large breast reconstruction

Official title: Advanced 3D auxetic biodegradable implant for large volume breast reconstruction

Funded at Georgia Institute of Technology · NIH-11248043 · Data updated 2026-11-12

A flexible, biodegradable 3D‑printed implant designed to help women who need large‑volume breast reconstruction after cancer surgery.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionGeorgia Institute of Technology
NIH-funded
Lab location1 site (Atlanta, United States)
Project startDecember 13, 2024
Project endNovember 30, 2026
Funding year2026
Award (this year)$253,965
NIH project number5R21CA290907-02
Project IDNIH-11248043 on NIH RePORTER

Who could benefit from this research

Could help

Women who require large‑volume breast reconstruction after mastectomy or major tissue loss and who are seeking alternatives to permanent silicone or saline implants would be the likely future candidates.

Less likely to help

People seeking cosmetic breast augmentation without tissue loss, those needing only small-volume correction, or individuals with contraindications to implantable biomaterials are unlikely to benefit from this work.

What this research studies

Researchers are designing a 3D‑printed, auxetic (highly flexible) biodegradable implant to support regeneration of large volumes of breast tissue after mastectomy. The team will scale up the implant geometry and test its mechanical behavior using computer simulations, micro‑CT imaging, and lab mechanical tests to match native fat tissue properties. They will also measure biological performance in laboratory models to see whether the design supports tissue in‑growth and blood vessel formation. The work is primarily preclinical to optimize the implant before any future human testing.

Why it matters

Potential benefit: If successful, this could provide a biodegradable implant that better matches natural breast tissue, reduces long‑term complications from permanent silicone/saline implants, and promotes the body’s own tissue regeneration.

How similar studies have gone: Biodegradable scaffold approaches have shown promise but often regenerate limited tissue volume because of poor vascular ingrowth, and this auxetic large‑scale design represents a newer, largely preclinical approach.

Where this research is happening

  • Georgia Institute of Technology
    Atlanta, United States
    Active

Researchers

  • Principal investigator: Park, Jeong Hun — Georgia Institute of Technology
  • Study coordinator: Park, Jeong Hun

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.